Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$3.76
0.030.8%
Last update: Oct 21, 7:17 AM
$3.75
0.020.54%
Clene Inc (CLNN) Stock Price, Quote, News & History
CLNNNASDAQ
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative...
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Clene (NASDAQ:CLNN) through any online brokerage.
Other companies in Clene’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Moderna Inc (NASDAQ:MRNA).
Clene has a consensus price target of $31.29.
The stock price for Clene (NASDAQ: CLNN) is $3.75 last updated October 21, 2026 at 7:17 AM EDT.
There are no upcoming dividends for Clene.
Clene does not have any upcoming earnings scheduled.
There is no upcoming split for Clene.
Clene is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
